France investigates death of student who received AstraZeneca blow

France investigates death of student who received AstraZeneca blow

Credit: Public domain Pixabay / CC0

French authorities said on Tuesday they were investigating the death of a 26-year-old medical student days after receiving AstraZeneca’s COVID-19 vaccine, while stressing that no link had yet been made with the vaccine.

The student died on March 18 in the western city of Nantes, 10 days after receiving the blow from AstraZeneca.

Nantes public prosecutor Pierre Sennes said that an autopsy was performed on him a day after his death but that “it was necessary to carry out additional tests to determine the causes and circumstances of his death “.

The ANSM national watchdog said it had been informed of the man’s death “as part of our increased surveillance of thrombosis cases” and said so far that there was no clear link. with inoculation.

“This death is the subject of a thorough clinical investigation,” he said in a statement, indicating the student’s age at 24. The prosecution later said he was 26 years old.

News of the man’s death came five days after France and several other countries resumed AstraZeneca vaccinations after briefly withholding it due to reports of blood clots in a small number of people who received the drug. vaccine.

The French drug regulator recommends the vaccine for people aged 55 and over, as reports of blood clots have been reported in younger people.

The vaccine was backed by the World Health Organization and the EU medicines regulator, who said there was no evidence of a link to an increased risk of blood clots.

The WHO said the reported rates of so-called thromboembolic events after COVID-19 vaccines were in line with the usual number of people with these conditions.

Follow the latest news on the coronavirus epidemic (COVID-19)

© 2021 AFP

Citation: France probes the death of a student who received the AstraZeneca jab (March 23, 2021) retrieved on March 23, 2021 from -astrazeneca.html

This document is subject to copyright. Other than fair use for private study or research purposes, no part may be reproduced without written permission. The content is provided for information only.


Please enter your comment!
Please enter your name here